RT Journal Article
SR Electronic
T1 Search for the trend of COVID-19 infection following Farr’s law, IDEA model and power law
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.04.20090233
DO 10.1101/2020.05.04.20090233
A1 Bhattacharya, Srijit
A1 Islam, Moinul
A1 De, Alokkumar
YR 2020
UL http://medrxiv.org/content/early/2020/05/08/2020.05.04.20090233.abstract
AB Following power law, Farr’s law and IDEA model, we analyze the data of COVID-19 pandemic for India up to 2 May, 2020 and for Germany, France, Italy, the USA, Singapore, China and Denmark up to 26 April, 2020. The cumulative total number of infected persons as a function of elapsed time has been fitted with power law to find the scaling exponent (γ). The reduction in γ in different countries signals the reduction in the growth of infection, possibly, due to long-term Government intervention. The extent of infection and reproduction rate R0 of the same are also examined using Farr’s law and IDEA model. The new cases per day with time assume Gaussian bell shaped curve, obeying the rule that faster rise follows faster decay. In India and Singapore, the peak of the bell shaped curve is still elusive. It is found that, till date, countries such as Denmark and India implementing sooner lockdown have underwent lower number of new cases of infection. Daily variation shows, R0 of all the countries is reducing, ushering in fresh hopes to combat COVID-19. Finally, we try to make a prediction as to the date on which the different countries will come down to daily cases of infection as low as one hundred (100).Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding is involved.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data referred in our manuscript are available in the internet. https://github.com/CSSEGISandData/COVID-19. https://www.mohfw.gov.in/ https://coronavirus.jhu.edu/us-map